P53 mutation is frequent and might not give a growth advantage in rat bladder carcinogenesis in vivo

Makoto Asamoto, Angela M. Mann, Samuel Monroe Cohen

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Abnormalities of the p53 gene are frequently observed in human tumors, including urinary bladder carcinoma, suggesting that p53 plays an important role in human carcinogenesis. However, its role in rat bladder carcinogenesis is unclear. In this study, we investigated the presence of p53 mutations in 122 urinary bladder tumors induced in F344 rats in the following carcinogenesis models: (i) 0.2% N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT; 6 weeks) in the diet followed by 3% or 5% sodium saccharin in the diet, 5% sodium ascorbate, 3.12% calcium saccharin (CaSac), 1.34% sodium chloride (NaCl), 5.2% CaSac plus 1.34% NaCl, or basal diet alone (72 weeks); and (II) 0.2% FANFT, 0.05% N-(4-hydroxybutyl)nitrosamine in the drinking water, N-methyl-N-nitrosourea 20 mg/kg body wt, i.p. twice per week, or basal diet alone (4 weeks), followed by 3% uracil in the diet (20 weeks). Polymerase chain reaction-single-strand conformation polymorphism analysis and direct sequencing were performed for exons 5-8 in the ratp53 gene. We found nine tumors (7.4%) with p53 mutations. Two tumors had two mutations in the p53 gene. The tumors that had p53 mutations were relatively smaller than those that did not have p53 mutations. There were no mutation clusters among the treatments or hot-spots for p53 mutations. These results indicate that p53 mutation is infrequent in bladder carcinogenesis in rats, and when it does occur, it does not appear to provide a growth advantage.

Original languageEnglish (US)
Pages (from-to)455-458
Number of pages4
JournalCarcinogenesis
Volume15
Issue number3
DOIs
StatePublished - Mar 1 1994

Fingerprint

Carcinogenesis
Nutrition
Rats
Tumors
Mutation
Urinary Bladder
Tumor
Growth
Saccharin
Genes
FANFT
Diet
Sodium
Calcium
Nitrosamines
p53 Genes
Gene
Polymerase chain reaction
Sodium chloride
Neoplasms

ASJC Scopus subject areas

  • Cancer Research

Cite this

P53 mutation is frequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. / Asamoto, Makoto; Mann, Angela M.; Cohen, Samuel Monroe.

In: Carcinogenesis, Vol. 15, No. 3, 01.03.1994, p. 455-458.

Research output: Contribution to journalArticle

@article{7c4f26da5cbc41939040c2dc3f9dc630,
title = "P53 mutation is frequent and might not give a growth advantage in rat bladder carcinogenesis in vivo",
abstract = "Abnormalities of the p53 gene are frequently observed in human tumors, including urinary bladder carcinoma, suggesting that p53 plays an important role in human carcinogenesis. However, its role in rat bladder carcinogenesis is unclear. In this study, we investigated the presence of p53 mutations in 122 urinary bladder tumors induced in F344 rats in the following carcinogenesis models: (i) 0.2{\%} N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT; 6 weeks) in the diet followed by 3{\%} or 5{\%} sodium saccharin in the diet, 5{\%} sodium ascorbate, 3.12{\%} calcium saccharin (CaSac), 1.34{\%} sodium chloride (NaCl), 5.2{\%} CaSac plus 1.34{\%} NaCl, or basal diet alone (72 weeks); and (II) 0.2{\%} FANFT, 0.05{\%} N-(4-hydroxybutyl)nitrosamine in the drinking water, N-methyl-N-nitrosourea 20 mg/kg body wt, i.p. twice per week, or basal diet alone (4 weeks), followed by 3{\%} uracil in the diet (20 weeks). Polymerase chain reaction-single-strand conformation polymorphism analysis and direct sequencing were performed for exons 5-8 in the ratp53 gene. We found nine tumors (7.4{\%}) with p53 mutations. Two tumors had two mutations in the p53 gene. The tumors that had p53 mutations were relatively smaller than those that did not have p53 mutations. There were no mutation clusters among the treatments or hot-spots for p53 mutations. These results indicate that p53 mutation is infrequent in bladder carcinogenesis in rats, and when it does occur, it does not appear to provide a growth advantage.",
author = "Makoto Asamoto and Mann, {Angela M.} and Cohen, {Samuel Monroe}",
year = "1994",
month = "3",
day = "1",
doi = "10.1093/carcin/15.3.455",
language = "English (US)",
volume = "15",
pages = "455--458",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - P53 mutation is frequent and might not give a growth advantage in rat bladder carcinogenesis in vivo

AU - Asamoto, Makoto

AU - Mann, Angela M.

AU - Cohen, Samuel Monroe

PY - 1994/3/1

Y1 - 1994/3/1

N2 - Abnormalities of the p53 gene are frequently observed in human tumors, including urinary bladder carcinoma, suggesting that p53 plays an important role in human carcinogenesis. However, its role in rat bladder carcinogenesis is unclear. In this study, we investigated the presence of p53 mutations in 122 urinary bladder tumors induced in F344 rats in the following carcinogenesis models: (i) 0.2% N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT; 6 weeks) in the diet followed by 3% or 5% sodium saccharin in the diet, 5% sodium ascorbate, 3.12% calcium saccharin (CaSac), 1.34% sodium chloride (NaCl), 5.2% CaSac plus 1.34% NaCl, or basal diet alone (72 weeks); and (II) 0.2% FANFT, 0.05% N-(4-hydroxybutyl)nitrosamine in the drinking water, N-methyl-N-nitrosourea 20 mg/kg body wt, i.p. twice per week, or basal diet alone (4 weeks), followed by 3% uracil in the diet (20 weeks). Polymerase chain reaction-single-strand conformation polymorphism analysis and direct sequencing were performed for exons 5-8 in the ratp53 gene. We found nine tumors (7.4%) with p53 mutations. Two tumors had two mutations in the p53 gene. The tumors that had p53 mutations were relatively smaller than those that did not have p53 mutations. There were no mutation clusters among the treatments or hot-spots for p53 mutations. These results indicate that p53 mutation is infrequent in bladder carcinogenesis in rats, and when it does occur, it does not appear to provide a growth advantage.

AB - Abnormalities of the p53 gene are frequently observed in human tumors, including urinary bladder carcinoma, suggesting that p53 plays an important role in human carcinogenesis. However, its role in rat bladder carcinogenesis is unclear. In this study, we investigated the presence of p53 mutations in 122 urinary bladder tumors induced in F344 rats in the following carcinogenesis models: (i) 0.2% N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT; 6 weeks) in the diet followed by 3% or 5% sodium saccharin in the diet, 5% sodium ascorbate, 3.12% calcium saccharin (CaSac), 1.34% sodium chloride (NaCl), 5.2% CaSac plus 1.34% NaCl, or basal diet alone (72 weeks); and (II) 0.2% FANFT, 0.05% N-(4-hydroxybutyl)nitrosamine in the drinking water, N-methyl-N-nitrosourea 20 mg/kg body wt, i.p. twice per week, or basal diet alone (4 weeks), followed by 3% uracil in the diet (20 weeks). Polymerase chain reaction-single-strand conformation polymorphism analysis and direct sequencing were performed for exons 5-8 in the ratp53 gene. We found nine tumors (7.4%) with p53 mutations. Two tumors had two mutations in the p53 gene. The tumors that had p53 mutations were relatively smaller than those that did not have p53 mutations. There were no mutation clusters among the treatments or hot-spots for p53 mutations. These results indicate that p53 mutation is infrequent in bladder carcinogenesis in rats, and when it does occur, it does not appear to provide a growth advantage.

UR - http://www.scopus.com/inward/record.url?scp=0028206607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028206607&partnerID=8YFLogxK

U2 - 10.1093/carcin/15.3.455

DO - 10.1093/carcin/15.3.455

M3 - Article

C2 - 8118928

AN - SCOPUS:0028206607

VL - 15

SP - 455

EP - 458

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 3

ER -